Live Breaking News & Updates on Apmygenome 39s Preventive Genetic Test Cardiomap Is Available On Thyrocare Online Platform Mapmygenome Dna Based Solution Exclusively For Preventing And Managing Heart Conditions It Givesa Cardiac Risk Profile Common Cardiovascular Diseases As Part Of The New Strategic Collaboration

Hyderabad (Telangana) [India], September 16 (ANI/PNN): Thyrocare, one of India's leading healthcare service providers in the diagnostic segment, has joined with Mapmygenome to launch a genomics-based healthcare solution. Mapmygenome's health and wellness genetic tests will be available in major towns and cities across India through an online pharmacy platform. As a part of the partnership, Mapmygenome's preventive genetic test Cardiomap is available on Thyrocare's online platform. CardioMap is Mapmygenome's DNA-based solution exclusively for preventing and managing heart conditions. It gives a genetic cardiac risk profile for common cardiovascular diseases. As part of the new strategic collaboration, Mapmygenome plans to launch more of its preventive genetic tests with Thyrocare in the future. Talking about the partnership, Mapmygenome CEO Anu Acharya said, "We at Mapmygenome are very excited about this partnership as we make our affordable genomic tests more a ....

Andhra Pradesh , Caesar Sengupta , Hyderabad International Airport , Thyrocare Vice President , Whole Exome , Whole Genome Sequencing , Carrier Screening Tests , Telangana State Government , Hyderabad International , Whats App , Hyderabad Telangana India , Eptember 16 Ani Pnn Thyrocare , Ne Of India 39s Leading Healthcare Service Providers In The Diagnostic Segment , As Joined With Mapmygenome To Launcha Genomics Based Healthcare Solution 39s Health And Wellness Genetic Tests Will Be Available In Major Towns Cities Across India Through An Online Pharmacy Platform Asa Part Of The Partnership , Apmygenome 39s Preventive Genetic Test Cardiomap Is Available On Thyrocare Online Platform Mapmygenome Dna Based Solution Exclusively For Preventing And Managing Heart Conditions It Givesa Cardiac Risk Profile Common Cardiovascular Diseases As Part Of The New Strategic Collaboration , Apmygenome Plans To Launch More Of Its Preventive Genetic Tests With Thyrocare In The Future Talking About Partnership , Apmygenome Ceo Anu Acharya Said , Uot We At Mapmygenome Are Very Excited About This Partnership As Make Our Affordable Genomic Tests More Accessible To The Masses , Specially For The Millions Who May Be At Risk Gettinga Cardiovascular Disease Quot Here 39s What Dr Caesar Sengupta , Hyrocare Vice President Operations , Ad To Say About The Partnership , Uot We Are Very Excited To Step Into The World Of Human Genomics In Partnership With Mapmygenome Both Organisations Completely Aligned Vision Bringing Next Generation Diagnostic Solutions For Offering Affordable And Quality Preventive Healthcare Masses Cardiovascular Diseases Comprise 31 Per Cent Deaths Globally Area Major Reason India Also See An Increasing Number Young Individuals Getting Cardiomap Could Prove Be Revolutionary Predicting Information Early About Risk Developing Common Associated Traits , Besity Risk And Imbalances In Lipid Metabolism , Drug Responses , Lood Pressure Risk And For Other Lifestyle Related Disorders Quot Mapmygenome Is India 39s Leading Preventive Genomics Company That Inspires People To Be Proactive About Their Health Founded In 2013 , Apmygenome Started Witha Vision To Quot Touch 100 Million Lives And Savea By 2030 The Company Offers Personalised Health Solutions Based On Preventive Genomic Tests That Help People Understand Their Genetic Selves Combining Profiles ,